US launch carries great expectations

Set up to commercialise technology developed at UCC, Metabolomic Diagnostics has the global market in its sights as it prepares to launch the world’s first test for pre-eclampsia in early pregnancy, writes Trish Dromey.

CORK firm Metabolomic Diagnostics is preparing to launch the world’s first test for pre-eclampsia in early pregnancy on the US market next year.

The long-term aim is to sell the test to every country in the world and the expectation of company founder and chief executive Charles Garvey is that the company could earn revenues of tens of millions of euro within five years.